MAYO CLINIC ARIZONA
Engineering cell-based therapy for enhanced survival and durable function in vivo
Engineering cell-based therapy for enhanced survival and durable function in vivo is a funding opportunity from MAYO CLINIC ARIZONA, up to 416250, closing May 31, 2029.
May 31, 2029
(1035d left)Overview
Project Summary The long-term goal of my lab is to develop durable cell-based therapies for treating various chronic diseases. Engineered cells secreting therapeutic proteins are grafted into the body to act as biological drug-factories and provide an attractive strategy for long-term cure of diseases such as…